WebSep 13, 2024 · -The IND for AK-OTOF is the first to receive FDA clearance for a genetic form of hearing loss and the first for an AAV vector therapy with the potential to treat an inner … WebOct 18, 2024 · The company’s most advanced program, named AK-OTOF, uses an adeno-associated viral vector to deliver a healthy copy of a gene called OTOF, which creates a protein that’s essential for hearing. While this therapy is still in preclinical testing, Akouos hopes to develop it into a one-time fix for the estimated 200,000 people around the world …
OTOF mutation analysis with massively parallel DNA sequencing …
WebNov 7, 2024 · The designation is another key piece in the puzzle that helps advance Sensorion towards clinical development in OTOF-GT in 2024.” The FDA grants Rare … WebAug 11, 2024 · AK-OTOF was previously granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) by the U.S. Food and Drug Administration for this … isaacs fury for sale
OTOF mutation analysis with massively parallel DNA sequencing in 2,265
WebMar 11, 2010 · The predominance of the p.E1700Q mutation and the evidence of its founder effect indicate a distinct OTOF mutation spectrum in Taiwanese patients with AN. Mutations in the OTOF gene have been found to be common causes of auditory neuropathy (AN) in Caucasians. However, the prevalence and spectrum of OTOF mutations in other … WebSep 19, 2024 · In April 2024, FDA granted both Orphan Drug Designation and Rare Pediatric Disease Designation for AK-OTOF. AK-OTOF Gene Therapy. AK-OTOF is a dual adeno-associated viral (AAV) vector-based gene therapy intended to treat patients with OTOF-mediated hearing loss by delivering transgenes encoding OTOF to the inner hair cells … WebMar 21, 2024 · Entrez Gene Summary for OTOF Gene. Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded … isaacs furniture